Logo image of SNDA

SONIDA SENIOR LIVING INC (SNDA) Stock Fundamental Analysis

NYSE:SNDA - New York Stock Exchange, Inc. - US1404752032 - Common Stock - Currency: USD

24.71  -0.45 (-1.79%)

After market: 24.71 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SNDA. SNDA was compared to 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of SNDA have multiple concerns. SNDA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SNDA had negative earnings in the past year.
SNDA had a positive operating cash flow in the past year.
SNDA had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SNDA reported negative operating cash flow in multiple years.
SNDA Yearly Net Income VS EBIT VS OCF VS FCFSNDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

SNDA has a Return On Assets (0.96%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 5.95%, SNDA is in the better half of the industry, outperforming 65.42% of the companies in the same industry.
Industry RankSector Rank
ROA 0.96%
ROE 5.95%
ROIC N/A
ROA(3y)0.73%
ROA(5y)-8.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNDA Yearly ROA, ROE, ROICSNDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

SNDA has a Profit Margin of 2.22%. This is in the better half of the industry: SNDA outperforms 68.22% of its industry peers.
The Operating Margin and Gross Margin are not available for SNDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 2.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNDA Yearly Profit, Operating, Gross MarginsSNDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SNDA has more shares outstanding
Compared to 5 years ago, SNDA has more shares outstanding
Compared to 1 year ago, SNDA has about the same debt to assets ratio.
SNDA Yearly Shares OutstandingSNDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
SNDA Yearly Total Debt VS Total AssetsSNDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that SNDA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SNDA (0.21) is worse than 72.90% of its industry peers.
A Debt/Equity ratio of 4.58 is on the high side and indicates that SNDA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.58, SNDA is doing worse than 83.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.58
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC7.48%
SNDA Yearly LT Debt VS Equity VS FCFSNDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.34 indicates that SNDA has no problem at all paying its short term obligations.
The Current ratio of SNDA (2.34) is better than 77.57% of its industry peers.
SNDA has a Quick Ratio of 2.34. This indicates that SNDA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.34, SNDA belongs to the top of the industry, outperforming 81.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
SNDA Yearly Current Assets VS Current LiabilitesSNDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SNDA have decreased strongly by -22.72% in the last year.
SNDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.04%.
SNDA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.11% yearly.
EPS 1Y (TTM)-22.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.48%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y-12.71%
Revenue growth 5Y-11.11%
Sales Q2Q%15.57%

3.2 Future

Based on estimates for the next years, SNDA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.35% on average per year.
The Revenue is expected to grow by 6.44% on average over the next years.
EPS Next Y65.21%
EPS Next 2Y8.92%
EPS Next 3Y8.35%
EPS Next 5YN/A
Revenue Next Year3.74%
Revenue Next 2Y6.69%
Revenue Next 3Y6.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNDA Yearly Revenue VS EstimatesSNDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
SNDA Yearly EPS VS EstimatesSNDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SNDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNDA Price Earnings VS Forward Price EarningsSNDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

SNDA's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.59
SNDA Per share dataSNDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.92%
EPS Next 3Y8.35%

More info and screens

0

5. Dividend

5.1 Amount

SNDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONIDA SENIOR LIVING INC

NYSE:SNDA (2/21/2025, 8:04:01 PM)

After market: 24.71 0 (0%)

24.71

-0.45 (-1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)03-25 2025-03-25/amc
Inst Owners79.63%
Inst Owner Change5.64%
Ins Owners18.68%
Ins Owner Change-3.41%
Market Cap471.22M
Analysts43.33
Price Target25.5 (3.2%)
Short Float %3.55%
Short Ratio9.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP18.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)400%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.36
P/FCF N/A
P/OCF 337.79
P/B 3.66
P/tB 3.66
EV/EBITDA 40.59
EPS(TTM)-4.7
EYN/A
EPS(NY)-2.82
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.07
OCFY0.3%
SpS18.12
BVpS6.75
TBVpS6.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.96%
ROE 5.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.22%
GM N/A
FCFM N/A
ROA(3y)0.73%
ROA(5y)-8.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 4.58
Debt/FCF N/A
Debt/EBITDA 22.8
Cap/Depr 53.11%
Cap/Sales 6.28%
Interest Coverage N/A
Cash Conversion 5.39%
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 0.21
F-Score6
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)45.48%
Cap/Depr(5y)38.8%
Cap/Sales(3y)7.26%
Cap/Sales(5y)6.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.48%
EPS Next Y65.21%
EPS Next 2Y8.92%
EPS Next 3Y8.35%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y-12.71%
Revenue growth 5Y-11.11%
Sales Q2Q%15.57%
Revenue Next Year3.74%
Revenue Next 2Y6.69%
Revenue Next 3Y6.44%
Revenue Next 5YN/A
EBIT growth 1Y30.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year307.76%
EBIT Next 3Y74.97%
EBIT Next 5YN/A
FCF growth 1Y49.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.66%
OCF growth 3YN/A
OCF growth 5Y-21.94%